LEUKAEMIA (ACUTE MYELOID)
Clinical trials for LEUKAEMIA (ACUTE MYELOID) explained in plain language.
Never miss a new study
Get alerted when new LEUKAEMIA (ACUTE MYELOID) trials appear
Sign up with your email to follow new studies for LEUKAEMIA (ACUTE MYELOID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune booster aims to stop childhood cancer return after transplant
Disease control Not yet recruitingThis early-phase trial tests a new therapy called ThINKK in 12 children aged 2–12 who have had a stem cell transplant for leukemia or neuroblastoma. The therapy uses special immune cells to help the body's natural killer cells fight any remaining cancer cells. The main goal is to…
Matched conditions: LEUKAEMIA (ACUTE MYELOID)
Phase: PHASE1 • Sponsor: Michel Duval • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Scientists study immune cells to unlock better leukemia monitoring
Knowledge-focused Not yet recruitingThis study collects blood and bone marrow samples from 55 adults with acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndrome. Researchers will analyze natural killer (NK) cells and their interactions with cancer cells over time. The goal is to learn whi…
Matched conditions: LEUKAEMIA (ACUTE MYELOID)
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Apr 23, 2026 12:45 UTC